📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

SOCS2 is part of a highly prognostic 4-gene signature in AML and promotes disease aggressiveness. (2019)

First Author: Nguyen CH

Attributed to: Wellcome Trust MRC Cambridge Stem Cell Institute funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41598-019-45579-0

PubMed Identifier: 31235852

Publication URI: http://europepmc.org/abstract/MED/31235852

Type: Journal Article/Review

Volume: 9

Parent Publication: Scientific reports

Issue: 1

ISSN: 2045-2322